Page 22 - தனிப்பயனாக்கப்பட்டது மருந்து News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Maßgeschneidete Medizin gegen Blutkrebs kommt aus Sachsen
mdr.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mdr.de Daily Mail and Mail on Sunday newspapers.
New theory: What causes severe COVID and long-haul symptoms?
kare11.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kare11.com Daily Mail and Mail on Sunday newspapers.
Real world patient database and revenues rapidly growing Sensyne poised for accelerated international growth Oxford, U.K. 27 May 2021: Sensyne Health plc (LSE: SENS) ( Sensyne or the Company ), the Clinical AI company, today announces an update on trading for the financial year ended 30 April 2021 ( FY 2021 ), and an outlook statement. UPDATE ON TRADING · Robust financial performance: FY 2021 unaudited revenues of at least £9.0 million (FY 2020: £2.1 million audited). · Strong revenue growth driven by contracts with life sciences companies, with recognition of the majority of the £4.8 million minimum revenues from MagnifEye AI technology contract with Excalibur Health Services ( Excalibur ). · Cash and cash equivalents were £23.6 million (unaudited) and excludes receipt of majority of minimum revenue payments from the Excalibur contract (FY 2020: £31.7 million au
vimarsana © 2020. All Rights Reserved.